Anzeige
Mehr »
Samstag, 28.03.2026 - Börsentäglich über 12.000 News
Milliardenmarkt Drohnen: Entsteht hier der nächste Tech-Champion?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3DL7T | ISIN: SE0017769995 | Ticker-Symbol: BGLA
Tradegate
27.03.26 | 08:05
10,840 Euro
+0,84 % +0,090
1-Jahres-Chart
BIOGAIA AB Chart 1 Jahr
5-Tage-Chart
BIOGAIA AB 5-Tage-Chart
RealtimeGeldBriefZeit
10,58010,78027.03.
10,64010,74027.03.

Aktuelle News zur BIOGAIA Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
20.03.BIOGAIA: 10-year follow-up study shows infant probiotics are positively associated with a reduction of childhood functional abdominal pain2
17.03.BioGaia AB: BioGaia exercises option to acquire remaining shares in Nutraceutics130BioGaia exercises the option to acquire the remaining 20 percent of the shares in Nutraceutics, the parent company to BioGaia's exclusive distributor of BioGaia's own products in the USA. BioGaia...
► Artikel lesen
26.02.BioGaia AB extends long-standing distribution partnership with Ewopharma125BioGaia AB (NASDAQ: BIOG) has signed a renewed distribution agreement with Ewopharma. The extended agreement reinforces the companies' successful collaboration to date and reflects a shared ambition...
► Artikel lesen
18.02.Probiotikahersteller BioGaia wächst weiter4
12.02.BioGaia AB Ser. B Bottom Line Rises In Q4-
12.02.BioGaia AB: Year-end report January - December 2025176FOURTH QUARTER 2025 (Figures in parentheses refer to the corresponding period last year, unless otherwise specified.) Net sales amounted to SEK 440.6 million (364.8), an increase of SEK 75.7 million...
► Artikel lesen
BIOGAIA Aktie jetzt für 0€ handeln
03.02.BioGaia AB: BioGaia's results for the fourth quarter to exceed market expectations151(Figures in the brackets refer to the same period the previous year) During the fourth quarter of 2025, BioGaia's sales were positively affected by quarterly variations for individual orders of approximately...
► Artikel lesen
02.02.Invitation to media and analyst briefing for BioGaia Q4 2025 report2
03.12.25Neues Design, neue Produkte: BioGaia wird erwachsen3
28.10.25BioGaia AB and University of Gothenburg discovered a new role for bacteria present in the gut: serotonin production320Often considered as our "second brain", the human gut and its resident microbiota play a crucial bidirectional role communicating the brain (central nervous system) with the gut (enteric nervous system)...
► Artikel lesen
22.10.25BioGaia AB: Interim Management Statement January - September 2025228THIRD QUARTER 2025 Net sales amounted to SEK 326.6 million (304.0), an increase of SEK 22.7 million, or an increase of 7% (excluding foreign exchange effects an increase of 14%). Net sales in the...
► Artikel lesen
16.10.25The study on BioGaia's new patented strain L. reuteri BG-R46 published in Beneficial Microbes3
13.10.25Invitation to media and analyst briefing for BioGaia Q3 2025 report3
30.09.25BioGaia launches Prodentis FRESH BREATH, a probiotic promoting instant and long-lasting fresh breath while supporting healthy gums and teeth2
10.09.25BioGaia AB establishes its own distribution in Germany and Austria327BioGaia AB (NASDAQ: BIOG) establishes its own distribution in Germany and Austria through a newly formed subsidiary in Germany which will distribute and market BioGaia's products in both Germany and...
► Artikel lesen
18.07.25BioGaia AB: Interim Report January - June 2025324SECOND QUARTER 2025 Net sales amounted to SEK 404.7 million (384.1), an increase of SEK 20.6 million, or an increase of 5% (excluding foreign exchange effects an increase of 13.2%). Net sales in the...
► Artikel lesen
16.07.25BioGaia AB launches a subsidiary company - BioGaia New Sciences AB - dedicated to advancing microbiome research and innovation489As interest in biotics1 and their wide range of health applications continues to grow, BioGaia is proud to announce the launch of a subsidiary company, BioGaia New Sciences AB, dedicated to exploring...
► Artikel lesen
08.05.25Dividendenbekanntmachungen (08.05.2025)13.014 Unternehmen  ISIN-Code  Dividende (Währung)  Dividende (EUR)  ADDNODE GROUP AB  SE0017885767  1,15 SEK  0,1052 EUR  AG BARR PLC  GB00B6XZKY75  0,1376 GBP  0,1617 EUR  ALANTRA PARTNERS SA  ES0126501131 - 0...
► Artikel lesen
07.05.25BioGaia AB: Interim Management Statement January - March 2025421FIRST QUARTER 2025 Net sales amounted to SEK 366.3 million (369.8), a decrease of SEK 3.5 million, or a decrease of 1% (excluding foreign exchange effects a decrease of 3.6%). Net sales in the Pediatrics...
► Artikel lesen
19 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1